These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 32070335)

  • 1. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
    Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
    Chikata Y; Iwata H; Miyosawa K; Naito R; Koike T; Moriya S; Yasuda H; Funamizu T; Doi S; Endo H; Wada H; Ogita M; Dohi T; Kasai T; Isoda K; Okazaki S; Miyauchi K; Minamino T
    Cardiovasc Diabetol; 2024 Mar; 23(1):114. PubMed ID: 38555431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
    Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
    Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
    Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
    Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visit-to-visit HbA
    Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Bawamia BR; Egred M; Jackson M; Purcell I; Austin D; Zaman AG
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E416-E422. PubMed ID: 32134178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI.
    Chandrasekhar J; Dangas G; Baber U; Sartori S; Qadeer A; Aquino M; Vogel B; Faggioni M; Vijay P; Claessen BE; Goel R; Moreno P; Krishnan P; Kovacic JC; Kini A; Mehran R; Sharma S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):298-308. PubMed ID: 32162781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
    Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry.
    Ike A; Shirai K; Nishikawa H; Iwata A; Yahiro E; Sugihara M; Kawamura A; Uehara Y; Zhang B; Ogawa M; Mori K; Miura S; Saku K
    J Cardiol; 2015 May; 65(5):390-6. PubMed ID: 25128368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Comparison of Reservoir-Based Polymer-Free Amphilimus-Eluting Stents Versus Everolimus-Eluting Stents With Durable Polymer in Patients With Diabetes Mellitus: The RESERVOIR Clinical Trial.
    Romaguera R; Gómez-Hospital JA; Gomez-Lara J; Brugaletta S; Pinar E; Jiménez-Quevedo P; Gracida M; Roura G; Ferreiro JL; Teruel L; Montanya E; Fernandez-Ortiz A; Alfonso F; Valgimigli M; Sabate M; Cequier A
    JACC Cardiovasc Interv; 2016 Jan; 9(1):42-50. PubMed ID: 26762910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.
    Qiao Z; Bian X; Song C; Zhang R; Yuan S; Lin Z; Zhu C; Liu Q; Ma W; Dou K
    Cardiovasc Diabetol; 2024 Jun; 23(1):190. PubMed ID: 38824608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.